Clinical Trial Update: 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary Gliomas [EARLY_Phase 1]

View source ↗

Summary

This document reports an early-phase 1 clinical trial evaluating the diagnostic imaging agent 68Ga-NOTA-Aca-BBN(7-14) PET/CT in patients with primary glioma to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• 68Ga-NOTA-Aca-BBN(7-14) PET/CT (Gallium-68 NOTA-Aca-BBN(7-14) PET/CT)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Glioma | EARLY_Phase 1 | Status: UNKNOWN